In Situ trans Ligands of CD22 Identified by Glycan-Protein Photocross-linking-enabled Proteomics
Lists
Only you see this
Abstract
CD22, a regulator of B-cell signaling, is a siglec that recognizes the sequence NeuAcalpha2-6Gal on glycoprotein glycans as ligands. CD22 interactions with glycoproteins on the same cell (in cis) and apposing cells (in trans) modulate its activity in B-cell receptor signaling. Although CD22 predominantly recognizes neighboring CD22 molecules as cis ligands on B-cells, little is known about the trans ligands on apposing cells. We conducted a proteomics scale study to identify candidate trans ligands of CD22 on B-cells by UV photocross-linking CD22-Fc chimera bound to B-cell glycoproteins engineered to carry sialic acids with a 9-aryl azide moiety. Using mass spectrometry-based quantitative proteomics to analyze the cross-linked products, 27 glycoproteins were identified as candidate trans ligands. Next, CD22 expressed on the surface of one cell was photocross-linked to glycoproteins on apposing B-cells followed by immunochemical analysis of the products with antibodies to the candidate ligands. Of the many candidate ligands, only the B-cell receptor IgM was found to be a major in situ trans ligand of CD22 that is selectively redistributed to the site of cell contact upon interaction with CD22 on the apposing cell.
BibTeX
@inproceedings{ramya2010situ,
author = {T.N.C. Ramya and Eranthie Weerapana and Lujian Liao and Ying Zeng and Hiroaki Tateno and Liang Liao and John R. Yates and Benjamin F. Cravatt and James C. Paulson},
title = {{In Situ trans Ligands of CD22 Identified by Glycan-Protein Photocross-linking-enabled Proteomics}},
booktitle = {Molecular},
year = {2010},
doi = {10.1074/mcp.m900461-mcp200},
}Loading related content...